A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 on HSV Shedding in Adults With Recurrent Genital HSV-2 Infection.
Condition: Genital Herpes Interventions: Biological: UB-621; Other: Placebo Sponsor: United BioPharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2018 Category: Research Source Type: clinical trials
